Navigation Links
Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More

Former US president Bill Clinton has once again lent a helping hand to HIV/ AIDS victims. After a fallout between the Brazil government and drug giant Merck over pricey anti-retroviral drugs, the Clinton foundation has helped diffuse the situation. Clinching a deal with two Indian pharmaceutical companies Cipla and Matrix, Bill Clinton announced the tie-up with the companies to provide second-line AVR drugs and a next generation one-pill-a-day drug.

Cipla and Matrix agreed to price their drugs on a cost-plus basis and collaborate with Clinton Foundation HIV and AIDS Initiative (CHAI) to lower production costs, in part, by securing lower prices for key raw materials and by addressing major chemistry challenges.

These agreements lower prices for 16 formulations of ARVs, which will be available to 66 developing countries in Africa, Asia, Latin America and the Caribbean through the Clinton Foundations Procurement Consortium, a release from CHAI added.

Bill Clinton was quoted: Seven million people in the developing world are in need of treatment for HIV/AIDS. We are trying to meet that need with the best medicine available today, and at prices that low-and middle-income countries can afford. I applaud Cipla and Matrix for their commitment to lower the cost of new drugs at the forefront of the fight against AIDS, and I thank UNITAID for the funds.

The AIDS virus infects nearly 39 million people globally, and has killed 25 million people since it was identified 25 years ago. Virtually all (95 percent) of people infected with the virus live in the developing world.

Experts say that by the year 2010, nearly half a million people in developing countries will need the drugs which currently cost far more money than the majority of developing countries can afford.

As Clinton was reported saying- companies will not live or die because of high price premiums for AIDS drugs in middle-income countries, but pati ents may.

The former US president states that while he upholds the belief in intellectual property and understands that manufacturers need to earn profits to keep the discovery and supply of AIDS drugs sustainable, that creed should not prevent essential life-saving medicines reaching those who need them in low and middle-income countries.


'"/>




Related medicine news :

1. Clintons new problem - Is the outgoing American president suffering from skin cancer?
2. AIDS testing gets support from Bill Clinton
3. Bill Clinton On A Kill, To Bell The Bulge Out of Schools
4. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
5. Clinton, Gates Highlight Treatment, Discrimination of AIDS
6. Powerful Synergy: Botswana and Clinton foundation To Sign MOU
7. Clinton’s Nutrition Deal Cuts Junk Food on School Menu
8. Bill Clinton Says US Healthcare System Immoral
9. Hillary Clinton Speaks Up Strongly for Stem Cell Research
10. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
11. Kalam To Lay Foundation Of Vellore Research Center
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  Directors from Pharma To Market Pty Ltd and ... forces, resulting in the founding of Pharma To Market Pte Ltd, ... Market are pleased to announce their expansion into Asia ... Singapore . The company are delighted to appoint Joelle ... Singapore based entity. Joelle brings with her ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... Südkorea, 23. Februar 2017 LG Innotek hat ... vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der ... im Bereich zwischen 200 und 280 nm und eignet sich ... indem es ihre DNA zerstört. Das Produkt von LG ... ...
Breaking Medicine Technology: